"Thông tư số 31-TTg"

Nhấn vào bên dưới để tải tài liệu

Nếu chưa tìm được tài liệu, vui lòng

Thử tìm trên TàiLiệuTươi.com

Tìm kiếm tài liệu, văn bản Thông tư số 31-TTg

Genomics driven-oncology Partial prevalence Total prevalence Partial cancer prevalence Human lung carcinogen Mimic steroid hormones Hormone-related cancers Syndrome of inappropriate antidiuretic hormone Vasopressin-2 receptor antagonists Severe hyponatraemia Extrahepatic primary malignancy Frequently displayed extrahepatic Superior sulcus tumors Pancoast tumor Ion beam therapy Heavy ion therapy 17β-hydroxysteroid dehydrogenase type 10 Mutant Ras plays multiple functions Mitochondrial alteration Oral multi-tyrosine Reversion-inducing cysteine-rich protein Kinase angiogenesis inhibitor Kazal motifs Cells undergoing stress Integrin-β8 EphB4 receptor tyrosine kinase Cancers including prostate cancer Significantly worse prognosis Non-significance Tumor initiating stem-like cells TGFβ/Smad signaling Mammary carcinoma Epithelialmesenchymal transition EMT Epithelial-mesenchymal plasticity EMP Disseminated tumor cell DTC Mammary stem cells Renal mass Mammary progenitor cells Ablated renal tumour Clinician-reported tumor Oxaliplatin-based regimen RNA-seq-based expression β-catenin protein Heat shock protein inhibitors Metastatic urothelial carcinoma DNA copynumber profile Interim PET/CT Combined treatment Recurrent gliomas Wild-type epidermal growth factor receptor Small non-coding microRNAs Organ-confined tumors Clinical risk score Innovative biomarkers Trastuzumab + docetaxel Gene-chip analysis First-line neoadjuvant treatment HER2-positive tumors treated Caucasian cancer Metanephric adenoma Benign tumour MA subtypes Biological behaviour Clinicopathological characteristic Cell-cycle-checkpoint kinase 2 Adult tissue Breast cancer susceptibility gene 1 Indicating precise regulation BRCA1 germline mutation Glioblastoma malignancy Inhibit gene expression Antiestrogen resistance Aurora kinase B Antiestrogen therapy Flexible training schedules CellSearch System Retinoic acid receptors Hematopoietic cell differentiation Linear array γ-Glutamyl transferase Payer status γ-Glutamyl transferase 7 Malignant primary brain tumor ACT1 peptide Motor protein Kinesin-8 motor protein Bi-oriented chromosomes Kinesin proteins Sterol transporter Modulating lipid homeostasis Self-renewing Single leukemia stem cell Quiescent property Leukemia stem cell Anal neoplasms Anti-myeloma drugs Caspase-dependent apoptosis Cancer and sexuality Sexual frequency Sexual satisfaction

Tài liệu, văn bản bạn tìm kiếm

Peri-sinusoidal haemorrhage, Oxaliplatin toxicity presenting, Pathologic changes, Nodular regenerative hyperplasia, HNF1B gene, Physical activity recommendations, Hereditary Nonpolyposis, During cancer treatment, Liver neoplasm, Undergo lymphadenectomy, Preoperative serum CA125, Rolandic region, Drug efficiency, Shb deficiency, Restrict tumor angiogenesis, Toll-like receptor 3, Hepatitis B virus infections, Significant public health problem, Magnetic resonance lymphangiography, Several disadvantages, Less toxic treatments, Kinesin Eg5, VEGF pathway, Akt/mTOR pathway, Vascular metastasis, Dried blood spots, Finger-prick lancet, Antiproliferative properties, Multi-institutions, Post-transcriptional gene regulation, Eukaryotic Initiation factor 6, Peculiar translation initiation factor, Carcinoma-associated fibroblasts, Breast cancer pathogenesis, Breast cancer cell biology, Cytokine molecules mediating, Cancer immunology, Recruit macrophages, Tumor cell, Primary liver cancer, PLC worldwide, AEG-1, Tertiary lymphoid structures, Tumor frequently overexpresses, TGF-β1/Smads signaling pathway, Colon cancer metastasis, Basal-to-luminal transition, Multiple tyrosine kinase oncogene, Heterogeneous tumor tissue, Homology phosphotyrosyl phosphatase 2, Human sporadic non-metastatic, BTBC cell lines, Lactate dehydrogenase A, P38 MAP kinase, Satisfactory outcomes, Surface antigens, Sunitinib-refractory GIST, Phosphatidylinositol 3-kinase, Antitumor efficacy, Various cancers, Human colon carcinomas, Virus discovery, Structural maintenance of chromosomes 1A, Urine diacetylspermine, Clinical stage IA, Amyloid-β precursor protein, Significant correlation, Fibulin-5, Inhibiting tumor growth, Helium-3 MRI, Radiosurgery alone, Whole-brain irradiation, Emergency outcomes, Non-systematic, SEER-Medicare, VEGF receptor, Recurrent platinum-sensitive ovarian cancer, Primary treatment, Significant neuropathy, Non-squamous NSCLC, Statistical projection, Human mammary tumor virus, Viral oncogenesis, HIF-1 gene, Cyclin-dependent kinase 1, G2-M checkpoint, Cyclin-dependent kinase pathways, Cytoplasmic ratio, Prostaglandin metabolism, Lymph node-negative breast cancer, Sarcoid-like reaction, Multiple swollen lymph nodes, Non-caseating epithelioid granuloma, Annexin A1, Chemokine gene therapy, Formyl peptide receptors, Chemokine CXCL16, NKG2D ligands, Natural killer group 2, Liver perfusion, RNA containing nano-vesicles, Mixed phenotype acute leukemia, Complex chromosomal rearrangement, Promoter swapping, Gene dysregulation, Chinese adults with cancer, DEK inhibition, Irinotecan-based therapy, Anti-CD40, Tumor debulking, TLR7 agonist imiquimod, Fluorescent lamps, Indoor-photosensitivity, Perioperative targeted therapy, Clinical cohort, Prognosis research, Stereotactic ablative therapy, Established noninvasive treatment, Leiomyosarcomas represent, Non-uterine, Non-sudden cancer deaths, Multivariate logistic regressions, Mammalian sirtuin family, Deacetylate histone, Low-grade cancer, Ovarian serous carcinoma, Mutational heterogeneity, Arylamine N-acetyltransferase 1, Molecular differences, Ereceptor α positive, Weekly irinotecan, Keratin 13, Despite multimode, Postoperative microenvironment, Cachectic cancer, FoxO protein, Thrombin generation, D-Dimers, Risk assessment model, Calpain-9, Including signalling, Adverse survival, Quantify RAR beta 2, Nervous system neoplasm, Therapeutic regimens, DNAX accessory molecule-1, Adjuvant regimens, Baseline echocardiography prior, Human papillomavirus-induced, HPV16-positive cervical cancer cells, Functional contribution, Mammary duct, Metastatic malignancies, Trophoblast tumours, Rare childhood cancers, Receiver operator curves, Threonine kinase 33, Fadu cells, Relevant genes, NF-E2-related factor 2, Gastric cancer genomics, Transcription factor nuclear factor, Gastric cancer sequencing, Royal Marsden Hospital, BCR-ABL1 fusion gene, BCR-ABL1 mutations, Blood vessel density, Biliary function, Relative signal intensities, Tumour progression model, Isogenic cell line pair, Cancer targeting, Cell penetrating protein, Richter’s syndrome, ERBB signaling, Previously identified dermicidin, Survival factor, HER2-trogocytosis, Cell-surface membrane proteins, Squamous cell lung cancer, Epidermal growth factor receptor gene mutation, ER-negative status, Unresectable metastasis, Early plasma biomarkers, Fluoroquinolone-based oral treatment, Negative lymph nodes, Neo-adjuvant, PDGFRα gene, Human pancreatic cancer, Capecitabine-based chemoradiation, Potential phase III trial, Circadian variation, Drug disposition, Malignancies including pancreatic, Serum thymidine kinase 1, STK1 protein assays, Immune-mediated adverse events, Cell surface marker, Anti-human TK1 antibodies, Lung neuroendocrine tumor, Cancer-related lethality, Herpes virus-associated ubiquitin-specific protease 7, TK1 specific activity, Inhibitor altered senescence, Orthotopic tumors, Tumor vasculature, Cancer patients’ outcomes, Chronic comorbidities, Fibulin-4, Extracellular glycoproteins, Endothelial growth factor, S6 ribosomal protein, Current smoker, Papillary squamous cell carcinoma, Former smoker, Mexican children, Never smoker, Whole pelvic radiation therapy, Smoking specific, Clinical behavior, Phase III randomized, Non-toxic adjuvant therapy, Adenosquamos carcinoma, Postoperative intensity modulated radiotherapy, Reported outside clinical trials, Arab women, Primary cutaneous melanomas, Genetic profiling, Distinct therapeutic, Nodal micrometastases, DAPK methylation, Tumor promotion, Mutation frequencies, HPV persistence, Treatment centres, Gynecological malignancy-related mortality, Reducing generalizability, Tumour suppressor gene methylation, Chemoresistant nature, Treatment details, Concurrent chemoradiation, Chemotactic cytokine, Adiponectin receptors, Recurrent T1-2 nasopharyngeal carcinoma, Re-irradiation treatment, Long non-coding, Lung adenocarcinoma transcript 1, German tumour registry, Improved survival, Thrombotic treatment, Short tandem repeat, Non-triple-negative breast cancer, Personalized therapies, Vulvar carcinoma, Lauren classification, Clinical phenotype, Infrequent tumour, Distant organs, Anti-metastatic drug screening, Hormonal signaling, ROCK1 gene, Nasopharyngeal neoplasm, Stem cell marker, CNS metastases, During radiotherapy, Decreased survival, BRCA1 promoter methylation, Pathological significance, Obtained mainly, Surgico-pathological diagnosis, Bisdioxopiperazine dexrazoxane, Uncertain cardioprotective mechanism, Anthracycline doxorubicin, Renal pelvis, Global gene expression profiling, Receiver operator characteristics, Retrospective image fusion, Side-by-side analysis, Tissue factor pathway, Grey horse, Preoperative anemia, EGFR-tyrosine kinase inhibitor, Receptor blockade, Constitutive activation, Activated protein C resistance, DNA methylation analysis, Melanocytic neoplasms, Cox proportional hazard, KRAS kinases, Receptor conversion, Novel biological, Distant breast cancer metastases, HMGA gene overexpression, Reduced survival, Breast and prostate cancer, Expression of NRIF3, Mastermind-like, Wild-type KRAS, Genetically engineered mouse model, Multifactor dimensionality reduction, Human bone marrow mesenchymal cells, Cancer-associated stromal cells, Human colon adenocarcinoma, Multicentric cohort, Predicting thyroid cancer risk, Non-randomized clinical trials, Multiple molecular subtypes, Short-course radiotherapy, Allele-specific copy number analysis, Generalised phenomenon, Preoperative chemo-radiotherapy, Angiogenesis-related genes, 3′-UTR polymorphisms, Human multiple myeloma, Extrahepatic metastases, Plus oxaliplatin, Adrenal metastases, Incurable hematological malignancy, Wnt signaling pathways, Cell proliferation 4, 6-benzylthioinosine, Human HCC cells, 5-FU plus oxaliplatin, Modified molecule, Systemic HCC therapy, Wnt pathway activity, β-catenin accumulates, Egyptian women, 3D-image-guided, Two-dimensional high-dose-rate brachytherapy, Nasal type, Anti-CD30-targeted therapy, B16-F10 melanoma, Primary bone lymphoma, Types of thyroid malignancy, Secondary bone lymphoma, Adenosine generated, Promoting tumor growth, Thyroid enlarged, Undifferentiated thyroid carcinoma, A2B receptors, Endothelial outgrowth cells, E2F1 transcription factor, Combretastatin A-4 disodium phosphate, Tumour recruitment, Everolimus treatment, KI67 status, Extrathyroidal extension, Eukaryotic translation elongation factor 1, Macromolecular complexes, Biliary tract carcinoma, Sphingosine-1-phosphate receptor-1, Protein biosynthesis, Glycosphingolipid Gb3, Endogenous non-coding RNAs, TCGA database, Accumulating evidences, Potential oncogenic roles, Phenotypic features, Glioblastoma model systems, Advanced colorectal cancer, Chemotherapy respons, Numerous biological, Chromosome 17 centromere, Metastatic CRC, FUSE binding protein, Metastatic lung tumor, Aggravating factors, Multiprotein complexes, Angiogenesis inhibitor, Methylation status, V600 mutations, COX-2 in clinical gastric cancer, Dose-dense sequential chemotherapy, G-alpha proteins, Human gastrointestinal, Unadjusted cancer survival, Annexin-1 contributes, Uveal melanomas, Peripheral tolerance, Pathological consequence, Combination cetuximab, Pharmacodynamic biomarkers, Maximum tumor shrinkage, Central nervous system tumors, Carrying mutations, Oral multi-kinase inhibitor, Histological diagnosis according, Prospective diagnostic trial, Tumor shrinkage significantly, Prostatic hyperplasia, Identify therapeutic, Tumor suppressor miRNAs, Lysyl oxidase, Mature microRNAs, Thyroid conditions, Feedback mechanisms, Negative oestrogen receptor, Geographical mortality, Microtubule stabilizing agent

Tìm tài liệu, văn bản theo thể loại

Bài giảng, biểu mẫu, đáp án đề thi, bài kiểm tra, văn bản pháp luật, giáo trình, luận văn, mẫu slide, báo cáo, đồ án, sách, ebook, thơ, truyện, đề tài, bài tập lớn, luận án, đề án, chuyên đề, trắc nghiệm, tiểu luận tốt nghiệp, biểu mẫu hành chính, biểu mẫu kế toán, tiếng anh, thư viện chia sẻ giáo án điện tử,học tập, thực tập, tốt nghiệp, thạc sĩ, tiến sĩ, cao học, học liệu, brochure, tạp chí, violympic, soạn bài, soạn văn, lời giải hay, giải bài tập các môn để học tốt các môn Toán, Lý, Hóa, Văn, Anh, Sinh, Sử, Địa, GDCD các lớp tiểu học, THCS, THPT, đề thi, văn mẫu hay, luật việt nam, luật doanh nghiệp.

Đánh giá
Thông tư số 31-TTg - 4 sao (17 lượt)